These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28903565)

  • 1. Liquid Biopsies - the Clinics and the Molecules.
    Kubaczková V; Sedlarikova L; Bollová B; Sandecká V; Stork M; Pour L; Sevcikova S
    Klin Onkol; 2017; 30(Supplementum2):13-20. PubMed ID: 28903565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid biopsies for multiple myeloma in a time of precision medicine.
    Ferreira B; Caetano J; Barahona F; Lopes R; Carneiro E; Costa-Silva B; João C
    J Mol Med (Berl); 2020 Apr; 98(4):513-525. PubMed ID: 32246161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid biopsy: an evolving paradigm for the biological characterisation of plasma cell disorders.
    Mithraprabhu S; Chen M; Savvidou I; Reale A; Spencer A
    Leukemia; 2021 Oct; 35(10):2771-2783. PubMed ID: 34262132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrichment-Free Single-Cell Detection and Morphogenomic Profiling of Myeloma Patient Samples to Delineate Circulating Rare Plasma Cell Clones.
    Ndacayisaba LJ; Rappard KE; Shishido SN; Ruiz Velasco C; Matsumoto N; Navarez R; Tang G; Lin P; Setayesh SM; Naghdloo A; Hsu CJ; Maney C; Symer D; Bethel K; Kelly K; Merchant A; Orlowski R; Hicks J; Mason J; Manasanch EE; Kuhn P
    Curr Oncol; 2022 Apr; 29(5):2954-2972. PubMed ID: 35621632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of non-invasive liquid biopsy for mutational analysis and minimal residual disease assessment in extramedullary multiple myeloma.
    Long X; Xu Q; Lou Y; Li C; Gu J; Cai H; Wang D; Xu J; Li T; Zhou X; Xiao M; Wang Y; Mao X; Zhou J; Chen L
    Br J Haematol; 2020 Apr; 189(2):e45-e48. PubMed ID: 32191818
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic interrogation of circulating multiple myeloma cells at single-cell resolution.
    Lohr JG; Kim S; Gould J; Knoechel B; Drier Y; Cotton MJ; Gray D; Birrer N; Wong B; Ha G; Zhang CZ; Guo G; Meyerson M; Yee AJ; Boehm JS; Raje N; Golub TR
    Sci Transl Med; 2016 Nov; 8(363):363ra147. PubMed ID: 27807282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid Biopsy: Current Status and Future Perspectives.
    Mader S; Pantel K
    Oncol Res Treat; 2017; 40(7-8):404-408. PubMed ID: 28693023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid biopsy and its role in an advanced clinical trial for lung cancer.
    Johann DJ; Steliga M; Shin IJ; Yoon D; Arnaoutakis K; Hutchins L; Liu M; Liem J; Walker K; Pereira A; Yang M; Jeffus SK; Peterson E; Xu J
    Exp Biol Med (Maywood); 2018 Feb; 243(3):262-271. PubMed ID: 29405770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.
    Besse L; Sedlarikova L; Kryukov F; Nekvindova J; Radova L; Slaby O; Kuglik P; Almasi M; Penka M; Krejci M; Adam Z; Pour L; Sevcikova S; Hajek R
    PLoS One; 2015; 10(9):e0137294. PubMed ID: 26389804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring Plasma Cell Dyscrasias With Cell-free DNA Analysis.
    Ntanasis-Stathopoulos I; Gavriatopoulou M; Terpos E; Fotiou D; Kastritis E; Dimopoulos MA
    Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e905-e909. PubMed ID: 32723621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
    Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
    Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications.
    Anderson KC; Auclair D; Kelloff GJ; Sigman CC; Avet-Loiseau H; Farrell AT; Gormley NJ; Kumar SK; Landgren O; Munshi NC; Cavo M; Davies FE; Di Bacco A; Dickey JS; Gutman SI; Higley HR; Hussein MA; Jessup JM; Kirsch IR; Little RF; Loberg RD; Lohr JG; Mukundan L; Omel JL; Pugh TJ; Reaman GH; Robbins MD; Sasser AK; Valente N; Zamagni E
    Clin Cancer Res; 2017 Aug; 23(15):3980-3993. PubMed ID: 28428191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive characterization of circulating and bone marrow-derived multiple myeloma cells at minimal residual disease.
    Waldschmidt JM; Anand P; Knoechel B; Lohr JG
    Semin Hematol; 2018 Jan; 55(1):33-37. PubMed ID: 29759150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid Biopsy in Oral Cancer.
    Lousada-Fernandez F; Rapado-Gonzalez O; Lopez-Cedrun JL; Lopez-Lopez R; Muinelo-Romay L; Suarez-Cunqueiro MM
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid biopsy approach in the management of prostate cancer.
    Riaz IB; Wang L; Kohli M
    Transl Res; 2018 Nov; 201():60-70. PubMed ID: 29936077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating exosomal long noncoding RNA PRINS-First findings in monoclonal gammopathies.
    Sedlarikova L; Bollova B; Radova L; Brozova L; Jarkovsky J; Almasi M; Penka M; Kuglík P; Sandecká V; Stork M; Pour L; Sevcikova S
    Hematol Oncol; 2018 Dec; 36(5):786-791. PubMed ID: 30144133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep sequencing reveals myeloma cells in peripheral blood in majority of multiple myeloma patients.
    Vij R; Mazumder A; Klinger M; O'Dea D; Paasch J; Martin T; Weng L; Park J; Fiala M; Faham M; Wolf J
    Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):131-139.e1. PubMed ID: 24629890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Myeloma: Detecting Genetic Changes Through Bone Marrow Biopsy and the Influence on Care.
    Catamero D
    Clin J Oncol Nurs; 2018 Jun; 22(3):263-265. PubMed ID: 29781462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring multiple myeloma by quantification of recurrent mutations in serum.
    Rustad EH; Coward E; Skytøen ER; Misund K; Holien T; Standal T; Børset M; Beisvag V; Myklebost O; Meza-Zepeda LA; Dai HY; Sundan A; Waage A
    Haematologica; 2017 Jul; 102(7):1266-1272. PubMed ID: 28385781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
    Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
    Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.